A massively parallel CRISPR-based screening platform for modifiers of neuronal depolarization
TL;DR
A platform to uncover genes affecting neuronal excitability in scalable CRISPR screens using CRISPRi and the fluorescent calcium integrator CaMPARI2 is developed to uncover molecular mechanisms controlling neuronal function in health and disease.
Abstract
Understanding the complex interplay between gene expression and neuronal activity is crucial for unraveling the molecular mechanisms underlying cognitive function and neurological disorders. Here, we developed pooled screens using CRISPR interference (CRISPRi) and the fluorescent calcium integrator CaMPARI2 to evaluate genetic modifiers of neuronal depolarization. Using this screening method, we evaluated 1343 genes for their effect on depolarization in a human iPSC-derived neuron model, revealing potential links to neurodegenerative and neurodevelopmental disorders. These genes include known regulators of neuronal excitability, such as TARPs and ion channels, as well as genes associated with autism spectrum disorder and Alzheimer’s disease not previously described to affect neuronal depolarization. This CRISPRi-based screening platform offers a versatile tool to uncover molecular mechanisms controlling neuronal function in health and disease. We currently lack scalable approaches to systematically reveal the genetic underpinnings of neuronal function in health and disease. Here, the authors develop a platform to uncover genes affecting neuronal excitability in scalable CRISPR screens.